146 related articles for article (PubMed ID: 10668448)
1. Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors.
Kingston AE; O'Neill MJ; Bond A; Bruno V; Battaglia G; Nicoletti F; Harris JR; Clark BP; Monn JA; Lodge D; Schoepp DD
Ann N Y Acad Sci; 1999; 890():438-49. PubMed ID: 10668448
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors.
Bruno V; Battaglia G; Kingston A; O'Neill MJ; Catania MV; Di Grezia R; Nicoletti F
Neuropharmacology; 1999 Feb; 38(2):199-207. PubMed ID: 10218860
[TBL] [Abstract][Full Text] [Related]
3. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo.
Meli E; Picca R; Attucci S; Cozzi A; Peruginelli F; Moroni F; Pellegrini-Giampietro DE
Pharmacol Biochem Behav; 2002 Sep; 73(2):439-46. PubMed ID: 12117599
[TBL] [Abstract][Full Text] [Related]
4. Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists.
Johnson MP; Kelly G; Chamberlain M
J Neuroendocrinol; 2001 Aug; 13(8):670-7. PubMed ID: 11489083
[TBL] [Abstract][Full Text] [Related]
5. 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1] pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia.
Pellegrini-Giampietro DE; Cozzi A; Peruginelli F; Leonardi P; Meli E; Pellicciari R; Moroni F
Eur J Neurosci; 1999 Oct; 11(10):3637-47. PubMed ID: 10564371
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795.
Kingston AE; O'Neill MJ; Lam A; Bales KR; Monn JA; Schoepp DD
Eur J Pharmacol; 1999 Jul; 377(2-3):155-65. PubMed ID: 10456425
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat.
Pizzi M; Benarese M; Boroni F; Goffi F; Valerio A; Spano PF
Neuropharmacology; 2000 Mar; 39(5):903-10. PubMed ID: 10699456
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of agonists and antagonists acting at Group I metabotropic glutamate receptors in the thalamus in vivo.
Salt TE; Turner JP; Kingston AE
Neuropharmacology; 1999 Oct; 38(10):1505-10. PubMed ID: 10530812
[TBL] [Abstract][Full Text] [Related]
10. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
[TBL] [Abstract][Full Text] [Related]
11. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms.
Pellegrini-Giampietro DE; Peruginelli F; Meli E; Cozzi A; Albani-Torregrossa S; Pellicciari R; Moroni F
Neuropharmacology; 1999 Oct; 38(10):1607-19. PubMed ID: 10530822
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity.
Behrens MM; Strasser U; Heidinger V; Lobner D; Yu SP; McDonald JW; Won M; Choi DW
Neuropharmacology; 1999 Oct; 38(10):1621-30. PubMed ID: 10530823
[TBL] [Abstract][Full Text] [Related]
13. An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors.
Bruno V; Battaglia G; Copani A; Cespédes VM; Galindo MF; Ceña V; Sánchez-Prieto J; Gasparini F; Kuhn R; Flor PJ; Nicoletti F
Eur J Neurosci; 2001 Apr; 13(8):1469-78. PubMed ID: 11328342
[TBL] [Abstract][Full Text] [Related]
14. Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist.
Schoepp DD; Johnson BG; Wright RA; Salhoff CR; Monn JA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):175-80. PubMed ID: 9750002
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of group I metabotropic glutamate receptor responses in vivo in rats by a new generation of carboxyphenylglycine-like amino acid antagonists.
Kingston AE; Griffey K; Johnson MP; Chamberlain MJ; Kelly G; Tomlinson R; Wright RA; Johnson BG; Schoepp DD; Harris JR; Clark BP; Baker RS; Tizzano JT
Neurosci Lett; 2002 Sep; 330(2):127-30. PubMed ID: 12231428
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo(1.1.1)pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity.
Mannaioni G; Attucci S; Missanelli A; Pellicciari R; Corradetti R; Moroni F
Neuropharmacology; 1999 Jul; 38(7):917-26. PubMed ID: 10428410
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
19. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
Bruno V; Battaglia G; Copani A; D'Onofrio M; Di Iorio P; De Blasi A; Melchiorri D; Flor PJ; Nicoletti F
J Cereb Blood Flow Metab; 2001 Sep; 21(9):1013-33. PubMed ID: 11524608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
